Arbutus Biopharma Corp held its 2023 Annual General and Special Meeting of Shareholders, where shareholders approved an amendment to the 2016 Omnibus Share and Incentive Plan to increase the number of common shares authorized for issuance and the number of common shares that may be issued pursuant to incentive stock options.